Cargando…
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market
The manufacturing process for biological products is complex, expensive and critical to the final product, with an impact on their efficacy and safety. They have been increasingly used to treat several diseases, and account for approximately 50% of the yearly budget for the Brazilian public health s...
Autores principales: | Scheinberg, Morton Aaron, Felix, Paulo Antonio Oldani, Kos, Igor Age, Andrade, Maurício De Angelo, Azevedo, Valderilio Feijó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178857/ https://www.ncbi.nlm.nih.gov/pubmed/30231147 http://dx.doi.org/10.1590/S1679-45082018RW4175 |
Ejemplares similares
-
The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018) -
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
por: Urbano, Paulo César Martins, et al.
Publicado: (2014) -
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021) -
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
por: Moots, Robert, et al.
Publicado: (2017) -
Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)